Completed

Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Retinovascular Diseases

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Cardiovascular Diseases+15

+ Diabetic Angiopathies

+ Endocrine System Diseases

Over 18 Years
See all eligibility criteria
How is the trial designed

Observational
Study Start: March 1998
See protocol details

Summary

Principal SponsorNational Eye Institute (NEI)
Last updated: July 2, 2017
Sourced from a government-validated database.Claim as a partner

Study start date: March 6, 1998

Actual date on which the first participant was enrolled.

This protocol is designed for the screening of patients with presumed retinovascular diseases. It serves as a first step for individuals who may be eligible and wish to participate in National Eye Institute clinical research studies of retinovascular diseases. Each individual will be thoroughly evaluated during the screening process to determine if they are suitable candidates for inclusion in any of the National Eye Institute ongoing studies. The screening evaluation will include past and current medical histories and an appropriate physical examination, namely a comprehensive eye exam. Other routine diagnostic procedures and tests may also be completed in order to help determine a subject's eligibility. These tests and procedures are of minimal risk and will be described in more detail in section III: "Study Procedures." Once the screening process is completed and their eligibility is assessed, the subjects will be informed of their options to participate in one or more of the current clinical research studies. If no appropriate protocol is identified, recommendations for other treatment options may be given to the individual, their primary doctor, or referring physician.

NCT00001733
Principal SponsorNational Eye Institute (NEI)
Last updated: July 2, 2017
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

2000 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Cardiovascular DiseasesDiabetic AngiopathiesEndocrine System DiseasesEye DiseasesMetabolic DiseasesMetaplasiaNutritional and Metabolic DiseasesPathologic ProcessesRetinal DegenerationPathological Conditions, Signs and SymptomsVascular DiseasesGlucose Metabolism DisordersDiabetes ComplicationsDiabetes MellitusDiabetic RetinopathyMacular DegenerationNeovascularization, PathologicRetinal Diseases

Criteria

INCLUSION/EXCLUSION CRITERIA Inclusion and exclusion criteria vary with the particular protocol for which a patient is being screened. In addition to those diagnoses currently under study, subjects with unknown conditions that require the establishment of a diagnosis may be eligible for inclusion in this study. All studies of retinovascular diseases require the subject to have minimum age of 18 years in both men and women.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, United StatesOpen National Institutes of Health Clinical Center, 9000 Rockville Pike in Google Maps
CompletedOne Study Center